Properties |
Information |
PhytoCAT-ID |
PhytoCAT-736 |
Phytochemical name or plant extracts |
Paeoniflorin |
PMID |
27175085 |
Literature evidence |
This finding provides evidence that PF can serve as a therapeutic agent for the treatment of breast cancer. |
IUPAC name |
[(1R,2S,3R,5R,6R,8S)-6-hydroxy-8-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9,10-dioxatetracyclo[4.3.1.02,5.03,8]decan-2-yl]methyl benzoate |
Phytochemicals’ class or type of plant extracts |
Monoterpene |
Source of phytochemicals or plant Extracts |
Paeonia lactiflora |
|
Geographical availability |
Amur, China North-Central, China South-Central, China Southeast, Chita, Inner Mongolia, Khabarovsk, Manchuria, Mongolia, Primorye |
Plant parts |
Root |
Other cancers |
Breast cancer |
Target gene or protein |
PI3K, AKT, HIF-1α, NOTCH‑1 and HES‑1 |
Gene or Protein evidence |
Furthermore, PF prevented hypoxia-induced expression of phosphorylated PI3K and Akt in MDA-MB-231 cells. In conclusion, PF prevented hypoxia-induced EMT in breast cancer cells by inhibiting HIF-1α expression via modulation of PI3K/Akt signaling pathway. NOTCH‑1 and HES‑1 protein levels demonstrated a similar trend to the mRNA levels, whereby an increase in the concentration of PF was associated with a decrease in NOTCH‑1 and HES‑1 protein expression levels. |
Target pathways |
PI3K/Akt signaling pathway, NOTCH‑1 signaling pathway |
IC50 |
NA |
Potency |
The results presented in this study demonstrate that PF blocks the migration and invasion of breast cancer cells by repressing EMT under hypoxic conditions. PF also significantly attenuated the hypoxia-induced increase in HIF-1α level. |
Cell line/ mice model |
MDA-MB-231 |
Additional information |
This finding provides evidence that PF can serve as a therapeutic agent for the treatment of breast cancer. |
PubChem ID |
442534 |
Additional PMIDs |
31858611 27175085 29115554 |
Additional sources of information |
https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:711802-1 |
Safety |
NA |